Fluid Imaging Technologies Seeks Submissions for Research Grant - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Fluid Imaging Technologies Seeks Submissions for Research Grant



Fluid Imaging Technologies announced a call for submissions for its Life Sciences & Materials Research Grant. Graduate students and senior undergraduates enrolled at a North American college or university who are studying biotechnology, biochemistry, material science/engineering, or related fields with an interest in micro-particle analysis are encouraged to apply for the use of a FlowCAM dynamic imaging particle analyzer to support their research.
 
The winner of the award will receive use of a FlowCAM for a period of up to four months, instrument training and on-going technical support, and a paid trip to an appropriate North American conference within 12 months of project completion to share the results of their work.  Judging criteria will include scientific merit, appropriate use of the FlowCAM, and the ability to obtain measurable results during a research period of four months. Proposals are due May 16, 2014.

Source:Fluid Imaging Technologies

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here